ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1739

Vδ1, Vδ2, and Other γδT Cells in Blood and Synovium of Rheumatoid Arthritis and Other Autoimmune Arthritides

Anna Helena Jonsson1, Michael Gurish1, Lauren Henderson2, Peter Nigrovic1 and Michael Brenner3, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: juvenile idiopathic arthritis (JIA), Rheumatoid arthritis (RA), spondylarthritis and synovial fluid, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Innate-like T cells comprise on average 10-15% of peripheral T cell and have T-cell receptors (TCRs) that engage ligands other than classic HLA class I or class II molecules displaying peptide. These cell types are characterized by a poised state at baseline, enabling rapid cytokine production upon stimulation. Innate-like T cells include natural killer T (NKT) cells, mucosal associated invariant T (MAIT) cells, and γδT cells, which in turn are divided into subsets based on their TCRδ gene expression (Vδ1, Vδ2, Vδ3, etc). The exact ligands for most γδTCR subsets are not clear, and there are indications that γδT cells can be activated independently of the TCR via NKG2D, which binds stress-induced ligands such as MICA and MICB, which are expressed in inflammatory synovium.

Methods: Synovial fluid mononuclear cells were collected from patients with clinical diagnoses of seropositive rheumatoid arthritis (RA), seronegative RA, spondyloarthritis (SpA), and juvenile idiopathic arthritis (JIA). Peripheral blood mononuclear cells were collected from patients with seropositive RA, seronegative RA, SpA, and JIA and from healthy controls (HC). We assessed the frequency and phenotypes of Vδ1, Vδ2, and other γδT cells using flow cytometry. We also stimulated synovial fluid mononuclear cells with CD3/CD28 beads or with phorbol myristate acetate (PMA) and ionomycin and measured cytokine production by Vδ1 and Vδ2 cells by intracellular cytokine staining. Statistics were performed by Kruskal-Wallis test.

Results: Vδ1 cells are enriched in synovial fluid from patients with JIA (7.61±4.07% vs 0.78±0.57% in HC blood, p<0.05), whereas non-Vδ1/Vδ2 γδT cells are elevated in synovial fluid from seropositive RA (7.20±4.05% vs 0.48±0.15% in seropositive RA blood, p<0.01). While a high frequency of all γδT cell subsets expressed NKG2D, other surface markers differed between γδT cell subsets and between blood and synovial fluid γδT cells. For example, CD69 was expressed at a high frequency on all three γδT cell subsets from synovial fluid from all four types of autoimmune arthritis but not from blood. CD25 is expressed at a higher rate among non-Vδ1/Vδ2 γδT cells from seropositive RA synovial fluid than from any of the other synovial fluid groups or from blood (36.7±16.4% vs 8.8±2.2% in seropositive RA blood, p<0.01). PD-1 was expressed by about half of Vδ1 and non-Vδ1/Vδ2 γδT cells from blood and was upregulated mainly on non-Vδ1/Vδ2 γδT cells in synovial fluid. Vδ2 cells, in contrast, expressed PD-1 at a low frequency in both blood and synovial fluid. Upon stimulation with PMA and ionomycin, both Vδ1 and Vδ2 cells from synovial fluid of all four types of autoimmune arthritis produced IFNγ and TNF at robust frequencies. However, only Vδ1 cells produced IL17A, with a frequency similar to CD4 T cells.

Conclusion: These findings suggest that Vδ1, Vδ2, and non-Vδ1/Vδ2 γδT cells represent cell populations with distinct functions in the blood and synovial fluid from patients with autoimmune arthritis. Additional studies are needed to further elucidate their roles in RA pathogenesis.


Disclosure: A. H. Jonsson, None; M. Gurish, None; L. Henderson, None; P. Nigrovic, None; M. Brenner, None.

To cite this abstract in AMA style:

Jonsson AH, Gurish M, Henderson L, Nigrovic P, Brenner M. Vδ1, Vδ2, and Other γδT Cells in Blood and Synovium of Rheumatoid Arthritis and Other Autoimmune Arthritides [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/v%ce%b41-v%ce%b42-and-other-%ce%b3%ce%b4t-cells-in-blood-and-synovium-of-rheumatoid-arthritis-and-other-autoimmune-arthritides/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/v%ce%b41-v%ce%b42-and-other-%ce%b3%ce%b4t-cells-in-blood-and-synovium-of-rheumatoid-arthritis-and-other-autoimmune-arthritides/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology